The trademark application SEROSTIM was filed by Merck KGaA, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on August 30, 2023, and it was registered by office on December 7, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).